Kate Ingarfield

1.1k total citations · 1 hit paper
17 papers, 550 citations indexed

About

Kate Ingarfield is a scholar working on Otorhinolaryngology, Molecular Biology and Oncology. According to data from OpenAlex, Kate Ingarfield has authored 17 papers receiving a total of 550 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Otorhinolaryngology, 4 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Kate Ingarfield's work include Head and Neck Cancer Studies (11 papers), Epigenetics and DNA Methylation (3 papers) and Family and Disability Support Research (3 papers). Kate Ingarfield is often cited by papers focused on Head and Neck Cancer Studies (11 papers), Epigenetics and DNA Methylation (3 papers) and Family and Disability Support Research (3 papers). Kate Ingarfield collaborates with scholars based in United Kingdom, Germany and Australia. Kate Ingarfield's co-authors include David I. Conway, Andrew Schache, Mark Gormley, Grant Creaney, Tim Waterboer, Andy Ness, Michael Pawlita, Miranda Pring, Alex D. McMahon and Angela Casbard and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Lancet Oncology and International Journal of Cancer.

In The Last Decade

Kate Ingarfield

15 papers receiving 543 citations

Hit Papers

Reviewing the epidemiology of head and neck cancer: defin... 2022 2026 2023 2024 2022 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Reviewing the epidemiology of head and neck cancer: definitions, trends and risk factors
    2022 335 citations Mark Gormley, Grant Creaney et al. BDJ profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kate Ingarfield United Kingdom 9 237 197 152 133 95 17 550
Grant Creaney United Kingdom 3 177 0.7× 107 0.5× 84 0.6× 72 0.5× 60 0.6× 3 354
Xiaolin Zhu China 13 110 0.5× 151 0.8× 104 0.7× 219 1.6× 110 1.2× 35 564
R. J. Sanderson United Kingdom 8 171 0.7× 110 0.6× 104 0.7× 75 0.6× 59 0.6× 14 374
S Whelan France 4 160 0.7× 126 0.6× 83 0.5× 87 0.7× 50 0.5× 8 344
Shaleen Kumar India 15 73 0.3× 105 0.5× 230 1.5× 165 1.2× 87 0.9× 53 695
Sarah Schimansky United Kingdom 8 97 0.4× 70 0.4× 96 0.6× 60 0.5× 29 0.3× 17 314
Kimberly R. Porter United States 7 497 2.1× 162 0.8× 292 1.9× 89 0.7× 64 0.7× 13 737
Cheryl Frank United States 17 392 1.7× 286 1.5× 433 2.8× 188 1.4× 32 0.3× 47 1.1k
Lucia Vassalli Italy 13 35 0.1× 223 1.1× 151 1.0× 51 0.4× 60 0.6× 30 420
Liangfang Shen China 13 87 0.4× 163 0.8× 125 0.8× 61 0.5× 55 0.6× 36 466

Countries citing papers authored by Kate Ingarfield

Since Specialization
Citations

This map shows the geographic impact of Kate Ingarfield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kate Ingarfield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kate Ingarfield more than expected).

Fields of papers citing papers by Kate Ingarfield

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kate Ingarfield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kate Ingarfield. The network helps show where Kate Ingarfield may publish in the future.

Co-authorship network of co-authors of Kate Ingarfield

This figure shows the co-authorship network connecting the top 25 collaborators of Kate Ingarfield. A scholar is included among the top collaborators of Kate Ingarfield based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kate Ingarfield. Kate Ingarfield is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Kroese, Biza Stenfert, Gemma Unwin, Richard P. Hastings, et al.. (2024). Emotional literacy programme in special schools for children with a learning disability in England: the ZF-SEND feasibility RCT. SHILAP Revista de lepidopterología. 12(15). 1–105.
2.
Moody, Gwenllian, David Gillespie, Kate Ingarfield, et al.. (2024). Teaching Early Reading Skills to Adults With Intellectual Disabilities Using a Support Worker/Family Carer Mediated Online Reading Programme: A Feasibility Randomised Controlled Trial. Journal of Applied Research in Intellectual Disabilities. 38(1). e13332–e13332.
3.
4.
Gormley, Mark, Grant Creaney, Andrew Schache, Kate Ingarfield, & David I. Conway. (2022). Reviewing the epidemiology of head and neck cancer: definitions, trends and risk factors. BDJ. 233(9). 780–786. 335 indexed citations breakdown →
5.
6.
Beynon, Rhona, Suzanne M Ingle, Ryan Langdon, et al.. (2022). Epigenetic biomarkers of ageing are predictive of mortality risk in a longitudinal clinical cohort of individuals diagnosed with oropharyngeal cancer. Clinical Epigenetics. 14(1). 1–1. 18 indexed citations
7.
Ingarfield, Kate, Alex D. McMahon, Katrina Hurley, et al.. (2021). Inequality in survival of people with head and neck cancer: Head and Neck 5000 cohort study. Head & Neck. 43(4). 1252–1270. 7 indexed citations
8.
Simon, Julia, Lea Schroeder, Kate Ingarfield, et al.. (2020). Epstein‐Barr virus and human papillomavirus serum antibodies define the viral status of nasopharyngeal carcinoma in a low endemic country. International Journal of Cancer. 147(2). 461–471. 21 indexed citations
9.
Langdon, Ryan, Rebecca C. Richmond, Hannah R. Elliott, et al.. (2020). Identifying epigenetic biomarkers of established prognostic factors and survival in a clinical cohort of individuals with oropharyngeal cancer. Clinical Epigenetics. 12(1). 95–95. 9 indexed citations
10.
Langdon, Ryan, Rhona Beynon, Kate Ingarfield, et al.. (2020). Epigenetic prediction of complex traits and mortality in a cohort of individuals with oropharyngeal cancer. Clinical Epigenetics. 12(1). 58–58. 3 indexed citations
11.
Schroeder, Lea, Miranda Pring, Kate Ingarfield, et al.. (2020). HPV driven squamous cell head and neck cancer of unknown primary is likely to be HPV driven squamous cell oropharyngeal cancer. Oral Oncology. 107. 104721–104721. 17 indexed citations
12.
Mayland, Catriona R, Kate Ingarfield, S.N. Rogers, et al.. (2020). Disease trajectories, place and mode of death in people with head and neck cancer: Findings from the ‘Head and Neck 5000’ population-based prospective clinical cohort study. Palliative Medicine. 34(5). 639–650. 16 indexed citations
13.
Brekel, Michiel W. M. van den, Ludi E. Smeele, Arash Navran, et al.. (2020). Patient‐reported swallowing function after treatment for early‐stage oropharyngeal carcinoma: Population‐based study. Head & Neck. 42(8). 1981–1993. 1 indexed citations
14.
Ingarfield, Kate, et al.. (2019). Inequality in the Survival of Patients With Head and Neck Cancer in Scotland. Frontiers in Oncology. 8. 673–673. 7 indexed citations
15.
Pring, Miranda, Amy Davies, Sam Leary, et al.. (2019). Squamous cell carcinoma of the nasal cavity: A descriptive analysis of cases from the head and neck 5000 study. Clinical Otolaryngology. 44(6). 961–967. 4 indexed citations
16.
Ingarfield, Kate, et al.. (2019). Determinants of long‐term survival in a population‐based cohort study of patients with head and neck cancer from Scotland. Head & Neck. 41(6). 1908–1917. 10 indexed citations
17.
Douglas, Catriona M., et al.. (2017). Presenting symptoms and long‐term survival in head and neck cancer. Clinical Otolaryngology. 43(3). 795–804. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Grant Creaney Breakdown of academic impact, for papers by Xiaolin Zhu Breakdown of academic impact, for papers by R. J. Sanderson Breakdown of academic impact, for papers by S Whelan Breakdown of academic impact, for papers by Shaleen Kumar Breakdown of academic impact, for papers by Sarah Schimansky Breakdown of academic impact, for papers by Kimberly R. Porter Breakdown of academic impact, for papers by Cheryl Frank Breakdown of academic impact, for papers by Lucia Vassalli Breakdown of academic impact, for papers by Liangfang Shen
Rankless by CCL
2026